The effect of sulfaphenazole and sulfadoxine on tolbutamide disposition in dwarf goats (Caprus hircus aegagrus)

Research in Veterinary Science

Volumn 63, Issue 3, 1997, Pages 269-272

  Zweers Zeilmaker, W M ^a   Wildschut, S ^a   Witkamp, R F ^a   Van Miert, A S J P A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SULFADOXINE; SULFAPHENAZOLE; SULFONAMIDE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HYDROXYLATION; DRUG PROTEIN BINDING; DRUG URINE LEVEL; FEMALE; GOAT; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL; NONHUMAN; PLASMA CLEARANCE; PLASMA PROTEIN BINDING;

ANIMALIA; CAPRA HIRCUS;

EID: 0031457819     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-5288(97)90032-1     Document Type: Article

References (26)

1. BALDWIN, S. J., BLOOMER, J. C., SMITH, G. J., AYRTON, A. D., CLARKE, S. E. & CHENERY,R. J. (1995) Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 25, 261-270
2. CHRISTENSEN, I. K., HANSEN, J. M. & KRISTENSEN, M. (1963) Sulphaphenazole-induced hypoglycaemic attacks in tulbutamide-treated diabetics. Lancet ii, 1298
3. DOECKE, C. J., VERONESE, M. E., POND, S. M., MINERS, J O , BIRKETT, D. J., SANSOM, L. N & McMANUS, M. E. (1991) Relationship between phenytom and tolbutamide hydroxylations in human liver microsomes. British Journal of Clinical Pharmacology 31, 125-130.
4. HEINZEL, G , WOLSZCAK, R & THOMANN, P. (1993) Topfit 2.0. Pharmacokinetic and pharmacodynamic data analysis system for the PC. Stuttgart, Gustav Fischer Verlag
5. TB (CYP2C): A major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver Life Sciences 52, 29-34
6. NELSON, D. R , KOYMANS, L., KAMATAKA, T., STEGEMAN, J. J., FEYEREISEN, R., WAXMAN, D. J , WATERMAN, M. R., GOTOH, O., COON, M. J., ESTABROOK, R. W., et al (1996) P450 superfamily: update on new sequences, gene mapping, accession number and nomenclature. Pharmacogenetics 6,1-42
7. NEWLANDS, A. J., SMITH, D. A., JONES, B C. & HAWKSWORTH, G. M. (1992) Metabolism of nonsteroidal anti-inflammatory drugs by cytochrome P4502C. British Journal of Clinical Pharmacology 34, 160P.
8. NIELSEN, P. (1973) Metabolism of sulfonamides in goats. Acta Veterinaria Scandinavica 14, 647-649
9. NIELSEN, P. & RASMUSSEN, F. (1976) Influence of age on half-life of trimethorpim and sulfadoxine in goats. Acta Pharmacologica et Toxicologica 30, 113-119
10. RELLLNG, M V., AOYAMA, T , GONZALEZ, F. J. & MEYER, U. A (1990) Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. The Journal of Pharmacology and Experimental Therapeutics 31, 125-130
11. 14C]naproxen O-demethylase activity in human liver microsomes Evidence for the involvement of cytochrome P450IA2 and P4502C9/10. Drug Metabolism and Disposition 24, 126-136
12. SIERSBAEK-NIELSEN, K., HANSEN, J. M , SKOWSTED. L., LUMHOLTZ, B & KAMPMANN, J. (1973) Sulphamethizole-induced inhibition of diphenylhydantoin and tolbutamide metabolism in man. Clinical Pharmacology and Therapeutics 14, 148
13. SOELDNER, J. A & STEINKE, J. (1965) Hypoglyceamia in tolbutamide-treated diabetis. Journal of the American Medical Association 193, 148
14. THIESSEN, J. J & ROWLAND, M. (1977) Kinetics of drug-drug interactions in sheep: tolbutamide and sulfadimethoxine The Journal of Pharmaceutical Sciences 66(8), 1063-1070
15. TRACY, T S , ROSENBLUTH, B. W., WRIGHTON, S. A., GONZALEZ, F. J. & KORZEKWA, K. R. (1995) Role of cytochrome P4502C9 and an allelic variant in the 4'-hydroxylation of (R)- and (S)-flurbiprofen. Biochemical Pharmacology 49, 1269-1275
16. VAN GOGH, H (1980) Pharmacokinetics of nine sulfonamides in goats Journal of Veterinary Pharmacology and Therapeutics 3, 69-81
17. VAN GOGH, H., WATSON, A. D J., NOUWS, J. F. M., NIEUWENHUIJS, J. & VAN MIERT, A S. J. P. A. M. (1989a) Effect of tick-borne fever (Ehrlichis phagocytophila) and trypanosomiasis (Trypmosoma brucie 1066) on the pharmacokinetics of sulfadimidine and its metabolites in goats. Drug Metabolism and Disposition 17, 1-6
18. VAN GOGH, H , VAN DEURZEN, E. J M., VAN DUIN, C. T M. & VAN MIERT, A. S. J. P. A M (1989b) Influence of gestation on the pharmacokinetics of four sulfonamides in goats. Research in Veterinary Science 48, 152-157
19. VERONESE, M. E., McMANUS, M. E., LAUPATTARAKASEM, P., MINERS, J O. & BIRKETT, D. J (1990) Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P450. Drug Metabolism and Disposition 18(3), 356-361
20. VERONESE, M E., MACKENZIE, P E., DOECKE, C. J., McMANUS, M E . MINERS, J O. & BIRKETT, D. J. (1991) Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9 Biochemical and Biophysical Research Communications 175(3), 1112-1118
21. VREE, T. B., HEKSTER, Y. A., NOUWS, J F. M. & DORRESTEIN, G. M. (1985) Pharmacokinetics of sulfonamides in animals. In Pharmacokinetics of Sulfonamides Revisited, Antibiotics and Chemotherapy, Vol. 34. Eds. T. B. Vree and Y. A Hekster. Basel, Karger pp 130-168
22. YAMAOKA, K., NAKAGAWA, T & UNO, T. (1978) Application of Aikaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations Journal of Pharmacokinetics and Biopharmaceutics 6, 165-175
23. ZHAO, J , LEEMANN, T. & DAYER, P. (1992) In vitro oxidation of oxicam NSAIDs by a human liver cytochrome P450. Life Sciences 51(8), 575-581
24. ZWEERS-ZEILMAKER, W M., BATZIAS, J., MAAS, R. F. M., HORBACH, G. J , MIERT VAN, A. S. J. P A. M. & WITKAMP, R F (1996a) In vitro and in vivo oxidative biotransformation in the dwarf goat Substrate activities and effects of inducers. Xenobiotica 26(11), 1131-1141
25. ZWEERS-ZEILMAKER, W M., HORBACH, G. J. & WITKAMP, R F (1996b) Effects of non-steroidal antiinflammatory drug and sulfonamides on hepatic cytochrome P4502C activity in vitro in goat and cattle. Journal of Veterinary Pharmacology and Therapeutics, submitted
26. ZWEERS-ZEILMAKER, W. M., HORBACH, G J. & WITKAMP, R. F. (1997), Differential inhibitory effects of phenytoin, diclofenac, phenylbutazone and a series of sulfonamides on hepatic cytochrome P4502C activity in vitro, and correlation with some molecular descriptors in the dwarf goat (Caprus hircus aegagrus). Xenobiotica 27, (8), 769-780